Cargando…
Behavioral characterization of the 6-hydroxidopamine model of Parkinson’s disease and pharmacological rescuing of non-motor deficits
BACKGROUND: Parkinson’s disease (PD) is a chronic neurodegenerative condition that is characterized by motor symptoms as a result of dopaminergic degeneration, particularly in the mesostriatal pathway. However, in recent years, a greater number of clinical studies have focused on the emergence of no...
Autores principales: | Carvalho, Miguel M, Campos, Filipa L, Coimbra, Bárbara, Pêgo, José M, Rodrigues, Carla, Lima, Rui, Rodrigues, Ana J, Sousa, Nuno, Salgado, António J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653696/ https://www.ncbi.nlm.nih.gov/pubmed/23621954 http://dx.doi.org/10.1186/1750-1326-8-14 |
Ejemplares similares
-
Ellagic acid improves hyperalgesia and cognitive deficiency in 6-hydroxidopamine induced rat model of Parkinson’s disease
por: Dolatshahi, Mojtaba, et al.
Publicado: (2015) -
Rodent models of Parkinson's disease: beyond the motor symptomatology
por: Campos, Filipa L., et al.
Publicado: (2013) -
Neuroprotective effects of seaweeds against 6-hydroxidopamine-induced cell death on an in vitro human neuroblastoma model
por: Silva, Joana, et al.
Publicado: (2018) -
Effect of Levodopa on Reward and Impulsivity in a Rat Model of Parkinson’s Disease
por: Carvalho, Miguel M., et al.
Publicado: (2017) -
SINEUP Non-coding RNA Targeting GDNF Rescues Motor Deficits and Neurodegeneration in a Mouse Model of Parkinson’s Disease
por: Espinoza, Stefano, et al.
Publicado: (2020)